| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1047772247 |
| P356 | DOI | 10.1038/SJ.ONC.1203236 |
| P698 | PubMed publication ID | 10602464 |
| P5875 | ResearchGate publication ID | 245595318 |
| P2093 | author name string | Y Nakamura | |
| S Gerondakis | |||
| T Pohl | |||
| M Grossmann | |||
| R Grumont | |||
| P2860 | cites work | Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome | Q24311679 |
| IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival | Q24323200 | ||
| The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis | Q24608044 | ||
| A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription | Q24644412 | ||
| Aberrant rel/nfkb genes and activity in human cancer | Q28140722 | ||
| The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition | Q28155838 | ||
| The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers | Q28267241 | ||
| NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses | Q28505819 | ||
| Immunological defects in mice with a targeted disruption in Bcl-3 | Q28506495 | ||
| Expression of relB is required for the development of thymic medulla and dendritic cells | Q28594949 | ||
| An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 | ||
| NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation | Q29618715 | ||
| Multiple signals converging on NF-kappaB. | Q33597403 | ||
| Control of development and immunity by rel transcription factors in Drosophila | Q33797143 | ||
| Control of apoptosis by Rel/NF-kappaB transcription factors | Q33797163 | ||
| Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel | Q33797168 | ||
| Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family | Q34317095 | ||
| Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality | Q35064315 | ||
| Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis | Q35189463 | ||
| Requirement for NF-kappaB in osteoclast and B-cell development | Q35199657 | ||
| An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis | Q35834615 | ||
| Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. | Q35913517 | ||
| The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations | Q35917603 | ||
| Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. | Q36377290 | ||
| Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture | Q36400143 | ||
| Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses | Q36400158 | ||
| B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells | Q36400425 | ||
| Functional redundancy of the nuclear factor kappa B inhibitors I kappa B alpha and I kappa B beta | Q36401827 | ||
| IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice | Q36559410 | ||
| Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor | Q37654865 | ||
| Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice | Q38289217 | ||
| Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2. | Q38342766 | ||
| Expression of constitutively active IkappaB beta in T cells of transgenic mice: persistent NF-kappaB activity is required for T-cell immune responses | Q39631389 | ||
| Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein I kappa B alpha | Q40016532 | ||
| Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo | Q40018450 | ||
| Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice | Q40956523 | ||
| Severe liver degeneration in mice lacking the IkappaB kinase 2 gene | Q40962152 | ||
| Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein | Q41043956 | ||
| Genetic approaches to study Rel/NF-kappa B/I kappa B function in mice | Q41595434 | ||
| Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase | Q41644582 | ||
| IkappaBalpha overexpression delays tumor formation in v-rel transgenic mice. | Q41855462 | ||
| p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice | Q41954424 | ||
| Limb and skin abnormalities in mice lacking IKKalpha | Q42470314 | ||
| Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses | Q42488424 | ||
| Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50. | Q42971521 | ||
| I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family | Q46153930 | ||
| Role of Rel/NF-kappaB transcription factors during the outgrowth of the vertebrate limb. | Q46700056 | ||
| The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation | Q47933661 | ||
| Inhibition of NF-kappaB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. | Q52188586 | ||
| Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Q52192178 | ||
| Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response | Q57607842 | ||
| Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression | Q62817899 | ||
| Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells | Q73479969 | ||
| RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells | Q77769122 | ||
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 6888-6895 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts | |
| P478 | volume | 18 |
| Q36888168 | A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-κB-dependent liver regeneration and cancer |
| Q38320987 | A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation. |
| Q40343429 | A genome-wide expression profile and system-level integration of nuclear factor kappa B regulated genes reveals fundamental metabolic adaptations during cell growth and survival |
| Q40730170 | A novel form of the RelA nuclear factor kappaB subunit is induced by and forms a complex with the proto-oncogene c-Myc. |
| Q54542919 | A20 and ABIN-3 possibly promote regression of trehalose 6,6'-dimycolate (TDM)-induced granuloma by interacting with an NF-kappa B signaling protein, TAK-1. |
| Q44018980 | APC0576, a novel inhibitor of NF-kappaB-dependent gene activation, prevents pro-inflammatory cytokine-induced chemokine production in human endothelial cells |
| Q28140722 | Aberrant rel/nfkb genes and activity in human cancer |
| Q29547882 | Activators and target genes of Rel/NF-kappaB transcription factors |
| Q40484483 | Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors |
| Q37042182 | Aldosterone activates NF-kappaB in the collecting duct. |
| Q28215829 | Alpha 5 beta 1 integrin activates an NF-kappa B-dependent program of gene expression important for angiogenesis and inflammation |
| Q34157973 | Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. |
| Q36368953 | Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response |
| Q28348814 | Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma) |
| Q62817748 | B Cell Growth Is Controlled by Phosphatidylinosotol 3-Kinase-Dependent Induction of Rel/NF-κB Regulated c-myc Transcription |
| Q24301605 | Bcl10 can promote survival of antigen-stimulated B lymphocytes |
| Q40778493 | Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity |
| Q24534877 | CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. |
| Q40580032 | Cg-Rel, the first Rel/NF-kappaB homolog characterized in a mollusk, the Pacific oyster Crassostrea gigas. |
| Q34514908 | Circuitry of nuclear factor kappaB signaling |
| Q33596981 | Computational modeling with forward and reverse engineering links signaling network and genomic regulatory responses: NF-kappaB signaling-induced gene expression responses in inflammation |
| Q40169287 | Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability |
| Q73588967 | Contribution of BCAP to maintenance of mature B cells through c-Rel |
| Q33797163 | Control of apoptosis by Rel/NF-kappaB transcription factors |
| Q33797143 | Control of development and immunity by rel transcription factors in Drosophila |
| Q34509419 | Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. |
| Q29617418 | Crosstalk in NF-κB signaling pathways |
| Q53379150 | Damped oscillations in a multiple delayed feedback NF-κB signaling module. |
| Q29248936 | Dendrosomal nanocurcumin and p53 overexpression synergistically trigger apoptosis in glioblastoma cells |
| Q28482484 | Development of B cells and erythrocytes is specifically impaired by the drug celastrol in mice |
| Q42944908 | Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development |
| Q30498322 | Differential utilization of NF-kappaB RELA and RELB in response to extracellular versus intracellular polyIC stimulation in HT1080 cells |
| Q37995686 | Dimer-specific regulatory mechanisms within the NF-κB family of transcription factors |
| Q39545592 | Effects of Thai medicinal herb extracts with anti-psoriatic activity on the expression on NF-κB signaling biomarkers in HaCaT keratinocytes |
| Q35096690 | Exogenous signal-independent nuclear IkappaB kinase activation triggered by Nkx3.2 enables constitutive nuclear degradation of IkappaB-alpha in chondrocytes |
| Q38348120 | Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis |
| Q28577016 | Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation |
| Q39962410 | Genetic analysis of NF- B/Rel transcription factors defines functional specificities |
| Q33797139 | How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex |
| Q36492044 | IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. |
| Q46607308 | IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis |
| Q73299772 | IKKβ Is Required for Peripheral B Cell Survival and Proliferation |
| Q35497838 | Identification of haplotype tag single nucleotide polymorphisms within the nuclear factor-κB family genes and their clinical relevance in patients with major trauma |
| Q44485224 | Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. |
| Q42175977 | IkappaB kinase alpha is essential for mature B cell development and function |
| Q36117584 | IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression. |
| Q40161044 | Impact on antibody responses of B-cell-restricted transgenic expression of a viral gene inhibiting activation of NF-κB and NFAT. |
| Q24625466 | Impaired B cell development and function in the absence of IkappaBNS |
| Q28588152 | Inactivation of BAD by IKK inhibits TNFα-induced apoptosis independently of NF-κB activation |
| Q38526804 | Information-theoretic sensitivity analysis: a general method for credit assignment in complex networks |
| Q40654754 | Inhibition of NF-kappaB by hydroquinone sensitizes human bone marrow progenitor cells to TNF-alpha-induced apoptosis |
| Q42005971 | Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50. |
| Q28280069 | Integrating cell-signalling pathways with NF-kappaB and IKK function |
| Q24170345 | Intracellular signal transduction of cells in response to carcinogenic metals |
| Q34754748 | It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. |
| Q28554490 | Kinase Inhibition Leads to Hormesis in a Dual Phosphorylation-Dephosphorylation Cycle |
| Q41002001 | Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide |
| Q63384216 | Modulation of nuclear factor-ϰB by human T cell leukemia virus type 1 tax protein : Implications for oncogenesis and inflammation |
| Q43077939 | NEMO gene mutations in Chinese patients with incontinentia pigmenti. |
| Q62806043 | NEMO/IKK gamma: linking NF-kappa B to human disease. |
| Q24803655 | NF-kB inhibitor blocks B cell development at two checkpoints |
| Q24804016 | NF-kappa B DNA-binding activity in embryos responding to a teratogen, cyclophosphamide |
| Q74244990 | NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B |
| Q34467751 | NF-kappa B defects in humans: the NEMO/incontinentia pigmenti connection |
| Q24805487 | NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction |
| Q35043854 | NF-kappaB activation by protein kinase C isoforms and B-cell function |
| Q35036569 | NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach |
| Q28301261 | NF-kappaB and the regulation of hematopoiesis |
| Q34080585 | NF-kappaB as a therapeutic target in chronic inflammation: recent advances |
| Q40504206 | NF-kappaB family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species |
| Q35592117 | NF-kappaB in mammary gland development and breast cancer |
| Q36940474 | NF-kappaB modulates aquaporin-2 transcription in renal collecting duct principal cells |
| Q28205043 | NF-kappaB regulation in the immune system |
| Q37480036 | NF-kappaB regulation: the nuclear response |
| Q34013841 | NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival |
| Q24290908 | NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100 |
| Q34283905 | NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression |
| Q28187604 | NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase |
| Q47556651 | NF-kappaB: Two Sides of the Same Coin. |
| Q58287167 | NF-κB Function in Inflammation, Cellular Stress and Disease |
| Q38178074 | NF-κB pathways in hematological malignancies |
| Q43518751 | NF-κB: Much Learned, Much to Learn |
| Q78952372 | NFkappaB and AP-1 DNA binding activity in patients with multiple sclerosis |
| Q35241505 | NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB. |
| Q26058119 | New insights into the role of nuclear factor-kB in cell growth regulation |
| Q38325314 | Nfkb 1 is dispensable for Myc-induced lymphomagenesis |
| Q38224263 | Non-conventional functions for NF-κB members: the dark side of NF-κB. |
| Q42167968 | Noncanonical NF-κB mediates the Suppressive Effect of Neutrophil Elastase on IL-8/CXCL8 by Inducing NKRF in Human Airway Smooth Muscle |
| Q37840104 | Novel IkB kinase inhibitors for treatment of nuclear factor-kB-related diseases |
| Q35579356 | Nuclear factor (NF)-kappaB proteins: therapeutic targets |
| Q28383134 | Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity |
| Q38585515 | Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury |
| Q28201984 | Nuclear transcription factor-kappaB as a target for cancer drug development |
| Q40773247 | PU.1/Spi-B regulation of c-rel is essential for mature B cell survival |
| Q34303584 | Pathways for self-tolerance and the treatment of autoimmune diseases. |
| Q24293239 | Peptide-induced negative selection of thymocytes activates transcription of an NF-kappa B inhibitor |
| Q28265675 | Physical and functional interaction of CARMA1 and CARMA3 with Ikappa kinase gamma-NFkappaB essential modulator |
| Q35104570 | Potential role of nuclear factor κB in diabetic cardiomyopathy. |
| Q52126536 | Rapid lipopolysaccharide-induced differentiation of CD14(+) monocytes into CD83(+) dendritic cells is modulated under serum-free conditions by exogenously added IFN-gamma and endogenously produced IL-10. |
| Q90041758 | Regulation of B-cell function by NF-kappaB c-Rel in health and disease |
| Q36573247 | Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides |
| Q39700531 | Regulation of c-Rel nuclear localization by binding of Ca2+/calmodulin |
| Q38774316 | Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit |
| Q35216951 | Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway |
| Q39345479 | Regulation of the exopolysaccharide from an anamorph of Cordyceps sinensis on dendritic cell sarcoma (DCS) cell line |
| Q34995852 | Rel/NF-kappa B/I kappa B signal transduction in the generation and treatment of human cancer |
| Q24800117 | Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells |
| Q34167602 | RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF |
| Q36499078 | RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation |
| Q34150275 | Relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR): new possibilities for the screening of anti-inflammatory and cytotoxic compounds |
| Q39647821 | Role of zeta PKC in B-cell signaling and function |
| Q28290234 | Roles for NF-kappaB in nerve cell survival, plasticity, and disease |
| Q28138811 | SIMPL is a tumor necrosis factor-specific regulator of nuclear factor-kappaB activity |
| Q35571851 | Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling. |
| Q33752186 | Selectivity of the NF-{kappa}B response |
| Q33302050 | Single TNFalpha trimers mediating NF-kappaB activation: stochastic robustness of NF-kappaB signaling. |
| Q34364544 | Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization |
| Q34353157 | Stochastic regulation in early immune response |
| Q38267049 | Targeting the NFκB signaling pathways for breast cancer prevention and therapy. |
| Q47928678 | Temporal and spatial profiling of nuclei-associated proteins upon TNF-alpha/NF-kappaB signaling. |
| Q36141554 | Th1/Th2 Differentiation and B Cell Function by the Atypical PKCs and Their Regulators |
| Q48366438 | The E3 ubiquitin ligase RNF114 and TAB1 degradation are required for maternal-to-zygotic transition |
| Q42512417 | The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha -deficient mice |
| Q28511124 | The MAGUK family protein CARD11 is essential for lymphocyte activation |
| Q36246420 | The RCAN1 inhibits NF-κB and suppresses lymphoma growth in mice |
| Q47072446 | The Rel protein DIF mediates the antifungal but not the antibacterial host defense in Drosophila |
| Q34023268 | The Rel/NF-kappa B family: friend and foe. |
| Q28140718 | The Rel/NF-kappaB signal transduction pathway: introduction |
| Q42129907 | The RelA nuclear localization signal folds upon binding to IκBα. |
| Q34682769 | The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression |
| Q34048761 | The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells |
| Q38320337 | The inhibitory effect of chimeric decoy oligodeoxynucleotide against NF-κB and Sp1 in renal interstitial fibrosis |
| Q37707035 | The regulator of calcineurin 1 (RCAN1) inhibits nuclear factor kappaB signaling pathway and suppresses human malignant glioma cells growth |
| Q35561576 | The role of Rel/NF-kappaB transcription factors in B lymphocyte survival |
| Q36402422 | The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes. |
| Q35991071 | The strength of indecisiveness: oscillatory behavior for better cell fate determination |
| Q36105771 | The transcription factor NF-kappaB as drug target |
| Q36731651 | The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms. |
| Q63407202 | The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion |
| Q43130560 | Thermodynamics reveal that helix four in the NLS of NF-kappaB p65 anchors IkappaBalpha, forming a very stable complex. |
| Q35577420 | Thicker than blood: conserved mechanisms in Drosophila and vertebrate hematopoiesis |
| Q33627717 | Tissue-specific target analysis of disease-associated microRNAs in human signaling pathways |
| Q35641452 | To die or not to die: the function of the transcription factor NF-kappaB in embryos exposed to stress |
| Q43462992 | Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy |
| Q36324925 | Turning down the system: counter-regulatory mechanisms in bone and adaptive immunity |
| Q28189055 | Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling |
| Q38309007 | Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor |
| Q36637897 | Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. |
| Q34007111 | Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa b activation |
| Q24315863 | ZBTB2 increases PDK4 expression by transcriptional repression of RelA/p65 |
| Q35848908 | c-Rel plays a key role in deficient activation of B cells from a non-X-linked hyper-IgM patient |
| Q36369604 | c-Rel regulates interleukin 12 p70 expression in CD8(+) dendritic cells by specifically inducing p35 gene transcription. |
Search more.